ZYDUS LIFESCIENCES
Back to Income Statement
|
ZYDUS LIFESCIENCES Last 5 Year Consolidated Net Profit History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Consolidated Net Profit | ₹4,526 Cr | ₹3,860 Cr | ₹1,960 Cr | ₹4,487 Cr | ₹2,134 Cr |
What is the latest Consolidated Net Profit of ZYDUS LIFESCIENCES ?
| Year | Consolidated Net Profit |
|---|---|
| Mar2026 | ₹4,526 Cr |
| Mar2025 | ₹3,860 Cr |
| Mar2024 | ₹1,960 Cr |
| Mar2023 | ₹4,487 Cr |
| Mar2022 | ₹2,134 Cr |
How is Consolidated Net Profit of ZYDUS LIFESCIENCES Trending?
| Years | Consolidated Net Profit | % Change | |
|---|---|---|---|
| Mar2026 | ₹4,526 Cr | 17.26 | |
| Mar2025 | ₹3,860 Cr | 96.88 | |
| Mar2024 | ₹1,960 Cr | -56.31 | |
| Mar2023 | ₹4,487 Cr | 110.32 | |
| Mar2022 | ₹2,134 Cr | - | |
Compare Consolidated Net Profit of peers of ZYDUS LIFESCIENCES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ZYDUS LIFESCIENCES | ₹111,570.4 Cr | -0.4% | -2.6% | 14% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹470,270.0 Cr | -1.5% | 2.5% | 14.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹222,224.0 Cr | 7.4% | 22.2% | 26.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹191,325.0 Cr | 3.1% | 4.3% | 38.5% | Stock Analytics | |
| CIPLA | ₹117,139.0 Cr | -1.6% | -1.4% | -6.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹96,876.6 Cr | 1.5% | -15.2% | -9.1% | Stock Analytics | |
ZYDUS LIFESCIENCES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ZYDUS LIFESCIENCES | -0.4% |
-2.6% |
14% |
| SENSEX | 2.2% |
0.9% |
-3.7% |
You may also like the below Video Courses